DK2417161T3 - ANTIBODIES AGAINST IL-17BR - Google Patents
ANTIBODIES AGAINST IL-17BR Download PDFInfo
- Publication number
- DK2417161T3 DK2417161T3 DK10712110.5T DK10712110T DK2417161T3 DK 2417161 T3 DK2417161 T3 DK 2417161T3 DK 10712110 T DK10712110 T DK 10712110T DK 2417161 T3 DK2417161 T3 DK 2417161T3
- Authority
- DK
- Denmark
- Prior art keywords
- antibody
- antibody molecule
- domain
- seq
- human
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16680809P | 2009-04-06 | 2009-04-06 | |
| GBGB0905972.6A GB0905972D0 (en) | 2009-04-06 | 2009-04-06 | Antibodies against IL-17BR |
| PCT/GB2010/000639 WO2010116123A1 (en) | 2009-04-06 | 2010-03-31 | Antibodies against il-17br |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2417161T3 true DK2417161T3 (en) | 2017-07-31 |
Family
ID=40750206
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK10712110.5T DK2417161T3 (en) | 2009-04-06 | 2010-03-31 | ANTIBODIES AGAINST IL-17BR |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US8586037B2 (enExample) |
| EP (1) | EP2417161B1 (enExample) |
| JP (1) | JP5767625B2 (enExample) |
| CN (1) | CN102482352B (enExample) |
| AU (1) | AU2010233535B2 (enExample) |
| CA (1) | CA2757104C (enExample) |
| DK (1) | DK2417161T3 (enExample) |
| ES (1) | ES2633767T3 (enExample) |
| GB (1) | GB0905972D0 (enExample) |
| WO (1) | WO2010116123A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130209485A1 (en) * | 2011-10-31 | 2013-08-15 | Riken | Therapeutic agent of non-allergic airway inflammation and/or non-allergic hyperresponsive airway |
| EP2858670B8 (en) * | 2012-06-12 | 2018-09-12 | Orega Biotech | Antagonists of il-17 isoforms and their uses |
| WO2013186236A1 (en) * | 2012-06-12 | 2013-12-19 | Orega Biotech | Antagonists of il-17 isoforms and their uses |
| US10793628B2 (en) * | 2014-06-30 | 2020-10-06 | Academia Sinica | Isolated antibodies against interleukin-17 receptor B (IL-17RB) for cancer therapy |
| US10372718B2 (en) * | 2014-11-03 | 2019-08-06 | SavantX, Inc. | Systems and methods for enterprise data search and analysis |
| EP4461311A3 (en) | 2015-01-20 | 2025-03-26 | Lankenau Institute for Medical Research | Methods and compositions for the treatment of diseases and disorders |
| JP7623939B2 (ja) * | 2018-07-09 | 2025-01-29 | マルチチュード インコーポレーテッド | 葉酸受容体アルファに特異的な抗体 |
| GB201820006D0 (en) * | 2018-12-07 | 2019-01-23 | Lifearc | Humanised anti-IL17BR antibody |
| PL3946377T3 (pl) | 2019-04-03 | 2026-04-20 | Orega Biotech | Terapie skojarzone oparte na inhibitorach pd1 i il-17b |
| US20230045494A1 (en) | 2020-02-28 | 2023-02-09 | Orega Biotech | Combination therapies based on ctla4 and il-17b inhibitors |
| WO2025118126A1 (zh) * | 2023-12-05 | 2025-06-12 | 中国抗体制药有限公司 | 抗il-17rb抗体、或其抗原结合片段或组合物的用途 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| JPS61134325A (ja) | 1984-12-04 | 1986-06-21 | Teijin Ltd | ハイブリツド抗体遺伝子の発現方法 |
| US5071972A (en) | 1986-01-31 | 1991-12-10 | Genetics Institute, Inc. | DNA sequences encoding novel thrombolytic proteins |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| EP0276846A3 (en) | 1987-01-29 | 1989-07-26 | Zymogenetics, Inc. | Colony-stimulating factor derivatives |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| ATE199392T1 (de) | 1992-12-04 | 2001-03-15 | Medical Res Council | Multivalente und multispezifische bindungsproteine, deren herstellung und verwendung |
| US6482923B1 (en) * | 1997-09-17 | 2002-11-19 | Human Genome Sciences, Inc. | Interleukin 17-like receptor protein |
| GB9809951D0 (en) | 1998-05-08 | 1998-07-08 | Univ Cambridge Tech | Binding molecules |
| ES2333772T3 (es) * | 1999-12-23 | 2010-03-01 | Genentech, Inc. | Polipeptidos homologos de il-17 y il-17r y sus utilizaciones terapeuticas. |
| WO2001057202A2 (en) | 2000-02-04 | 2001-08-09 | The Board Of Trustees Of The University Of Arkansas | Evi27 gene sequences and protein encoded thereby |
| TWI322154B (en) * | 2000-03-16 | 2010-03-21 | Amgen Inc | Il-17 receptor like molecules and uses thereof |
| GB0707505D0 (en) | 2007-04-18 | 2007-05-30 | Medical Res Council | Antibodies against il-25 |
| US20090068195A1 (en) | 2007-04-23 | 2009-03-12 | Wyeth | Methods and compositions for treating and monitoring treatment of il-13-associated disorders |
| US8454955B2 (en) | 2007-11-28 | 2013-06-04 | Riken | Methods for treating allergic airway inflammation, airway hypersensitivity, and eosinophilia |
| JP2011514335A (ja) | 2008-02-21 | 2011-05-06 | アムジェン インコーポレイテッド | Ｉｌ−１７ｒａ−ｉｌ−１７ｒｂアンタゴニストおよび該アンタゴニストの使用 |
| US9209965B2 (en) | 2014-01-14 | 2015-12-08 | Microsemi Semiconductor Ulc | Network interface with clock recovery module on line card |
-
2009
- 2009-04-06 GB GBGB0905972.6A patent/GB0905972D0/en not_active Ceased
-
2010
- 2010-03-31 EP EP10712110.5A patent/EP2417161B1/en active Active
- 2010-03-31 AU AU2010233535A patent/AU2010233535B2/en active Active
- 2010-03-31 DK DK10712110.5T patent/DK2417161T3/en active
- 2010-03-31 ES ES10712110.5T patent/ES2633767T3/es active Active
- 2010-03-31 CN CN201080022541.4A patent/CN102482352B/zh active Active
- 2010-03-31 CA CA2757104A patent/CA2757104C/en active Active
- 2010-03-31 JP JP2012504066A patent/JP5767625B2/ja active Active
- 2010-03-31 US US13/262,123 patent/US8586037B2/en active Active
- 2010-03-31 WO PCT/GB2010/000639 patent/WO2010116123A1/en not_active Ceased
-
2013
- 2013-10-17 US US14/056,559 patent/US8852589B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN102482352A (zh) | 2012-05-30 |
| ES2633767T3 (es) | 2017-09-25 |
| JP5767625B2 (ja) | 2015-08-19 |
| CA2757104C (en) | 2018-07-24 |
| EP2417161A1 (en) | 2012-02-15 |
| US20140044718A1 (en) | 2014-02-13 |
| EP2417161B1 (en) | 2017-05-24 |
| CA2757104A1 (en) | 2010-10-14 |
| CN102482352B (zh) | 2015-06-10 |
| JP2012522531A (ja) | 2012-09-27 |
| AU2010233535B2 (en) | 2014-02-27 |
| GB0905972D0 (en) | 2009-05-20 |
| AU2010233535A1 (en) | 2011-11-03 |
| US20120020985A1 (en) | 2012-01-26 |
| US8586037B2 (en) | 2013-11-19 |
| US8852589B2 (en) | 2014-10-07 |
| HK1170745A1 (en) | 2013-03-08 |
| WO2010116123A1 (en) | 2010-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2757104C (en) | Antagonistic il-17b receptor (il-17br) antibody | |
| US20240124596A1 (en) | Antibody molecule for human gm-csf receptor alpha | |
| DK2144934T3 (en) | Antibodies to IL-25 | |
| JP6883591B2 (ja) | 抗ヒトインターロイキン−１７ａモノクローナル抗体、その製造方法及び使用 | |
| AU2009299465B2 (en) | Antibodies against IL-25 | |
| HK1170745B (en) | Antibodies against il-17br | |
| HK1154022B (en) | Antibodies against il-25 |